Study of genetic variation profiles in liver cancer patients
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
To explore the features of genetic variation profiles in liver cancer patients
应用场景：
创建时间：
2021-12-09
相关数据集
Distinguishing metastatic from non-metastatic pheochromocytomas and paragangliomas using genetic alterations
Background: Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumors and collectively known as PPGLs. The prognosis of metastatic PPGLs is much poorer than that of non-metasta
NIAID Data Ecosystem30
The functional KEGG pathways enriched with genes located on the chromosomal segments with significant CNAs in all HCCs.
Note: The pathways that were significantly affected by the identfied CNAs were determined by Fisher' exact test.KEGG, Kyoto Encyclopedia of Genes and Genomes; CNA, copy number alteration.
Figshare2015-12-02 更新10
Pharmacogenomic profiling of intra-tumor heterogeneity by a large organoid biobank of liver cancer
Mendeley data 1: Immunofluorescence staining of P1 (HCC, shown in Fig. 1D) and P29 (ICC, shown in Data S1.3) organoids. HCC markers (AFP and Hepatocyte) and biliary markers (EPCAM and KRT19) were assa
NIAID Data Ecosystem00
Additional file 1 of Genomic subtyping of liver cancers with prognostic application
Additional file 1. Supplementary Tables S1-S6. Table S1. Clinical and pathological information on 110-Liver cohort. Table S2. SNV numbers in different sequence datasets on 110-Liver cohort. Table S3.
Figshare2024-02-14 更新20
MOESM2 of Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma
Additional file 2. The number of point mutations in 300 liver cancers and the function of 13 novel mutated genes.
Figshare2017-10-24 更新10
